Irving Steinberg, PharmD

Dr. Irving Steinberg has been with USC since 1985, and is Associate Dean for Faculty Affairs at the USC School of Pharmacy, Associate Professor of Clinical Pharmacy and Pediatrics at the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences and at the Keck School of Medicine of USC, and is Director of the Division of Pediatric Pharmacotherapy in the Department of Pediatrics at the Los Angeles General Medical Center (formally LAC+USC). Dr. Steinberg is a graduate of the University of Minnesota, where he completed his Pharm.D. degree, residency and an endowed fellowship in infectious diseases and pharmacokinetics. He maintains a busy clinical consultation practice with bedside and telemetric teaching of medical residents, represents the Department of Pediatrics on the Pharmacy and Therapeutics Committee for the past 31 years, and on the Antimicrobial and Medication Safety Subcommittees at LA General, and has served on medical expert panels for the Department of Health Services. He has published and presented numerous scientific papers and book chapters on pharmacokinetics in pediatrics and pregnancy, antimicrobials and drug resistance, antiseizure and cardiovascular drugs. He has been a primary content editor on anivirals and antifungals for the Redbook of the American Academy of Pediatrics. Areas of research emphasis include predicitve performance of pharmacokinetic models for dosing in children and novel pharmacotherapeutic applications of drugs such as amphotericin and erythromycin in neonates. This diversity in areas of expertise is reflected in his programmatic efforts and teaching, from bedside to classroom, at USC. He has trained numerous pediatric pharmacotherapy residents & fellows who have gone on to distinguished careers. Additionally, Dr. Steinberg is a noted national speaker for many physician and pharmacist audiences, and has given hundreds of lectures, grand rounds, and continuing education programs in 43 states in the US. His expertise in legal medicine is nationally regarded, and is sought-after in court and arbitration disputes involving pharmacologic and toxicologic issues. His opinions on topical disease and drug therapy news items have been viewed and read across many media outlets.

• Winter’s Basic Clinical Pharmacokinetics Valproic Acid. 2024; 472-496. . View in PubMed
• Am J Obstet Gynecol A randomized trial of unfractionated heparin dosing for thromboprophylaxis of prolonged antepartum hospitalizations. 2023; 228(1):S402-403. . View in PubMed
• What current and missing data can teach us about medication errors BMJ Qual Saf. 2021 02; 30(2):89-91. . View in PubMed
• Impact of diagnostic testing on pediatric patients with pharyngitis: Evidence from a large health plan Journal of Clinical Outcomes Management. 2021; 28(4):158-172. . View in PubMed
• Coronavirus research done too fast is testing publishing safeguards, bad science is getting through The Conversation. 2020. . View in PubMed
• Cardiac Problems in Pregnancy, Pharmacokinetics of drugs in pregnancy and lactation. 2019; 435-455. . View in PubMed
• Acyclovir Dosing and Acute Kidney Injury: Deviations and Direction J Pediatr. 2015 Jun; 166(6):1341-4. . View in PubMed
• Case 3: Fever, Vomiting, and Increased Sleepiness in a 4-year-old Girl Pediatr Rev. 2015 May; 36(5):222-4. . View in PubMed
• Pharmacoepidemiol Drug SafTrends in the Use of Prescription
  Medications Among Women of Reproductive Age by Pregnancy Status in the U. S. 2009-2020. 2023; 32(S1):507-508. . View in PubMed
• Renal tolerance with the use of intralipid-amphotericin B in low-birth-weight neonates Am J Perinatol. 1997 Aug; 14(7):377-83. . View in PubMed

• Kaplowitz, Neil
• Terrault, Norah
• Nadim, Mitra